Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
4.000
-0.120 (-2.91%)
At close: Oct 8, 2025, 4:00 PM EDT
3.950
-0.050 (-1.25%)
After-hours: Oct 8, 2025, 7:04 PM EDT
Entero Therapeutics Employees
Entero Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 7 or -77.78% compared to the previous year.
Employees
2
Change (1Y)
-7
Growth (1Y)
-77.78%
Revenue / Employee
n/a
Profits / Employee
-$8,688,661
Market Cap
6.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | -7 | -77.78% |
| Dec 31, 2023 | 9 | -1 | -10.00% |
| Dec 31, 2022 | 10 | -7 | -41.18% |
| Dec 31, 2021 | 17 | 5 | 41.67% |
| Dec 31, 2020 | 12 | 2 | 20.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ENTO News
- 6 days ago - Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus - Benzinga
- 7 days ago - ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI - Accesswire
- 7 days ago - ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand - Newsfile Corp
- 7 weeks ago - Entero Therapeutics, Inc. Announces Reverse Stock Split - Newsfile Corp
- 2 months ago - Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules - Newsfile Corp
- 4 months ago - FluroTech Ltd. Announces Change in Directors - Newsfile Corp
- 7 months ago - Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC - Newsfile Corp
- 8 months ago - Entero Therapeutics Appoints Richard Paolone as CEO - GlobeNewsWire